Filing Details
- Accession Number:
- 0001209191-19-015202
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-01 19:05:52
- Reporting Period:
- 2019-02-27
- Accepted Time:
- 2019-03-01 19:05:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1337334 | Steven Shak | 301 Penobscot Drive Redwood City CA 94063 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-02-27 | 25,000 | $17.18 | 360,479 | No | 4 | M | Indirect | Held by the Shak Family Trust |
Common Stock | Disposition | 2019-02-27 | 22,807 | $76.53 | 337,672 | No | 4 | S | Indirect | Held by the Shak Family Trust |
Common Stock | Disposition | 2019-02-27 | 2,193 | $77.29 | 335,479 | No | 4 | S | Indirect | Held by the Shak Family Trust |
Common Stock | Acquisiton | 2019-02-28 | 20,000 | $17.18 | 355,479 | No | 4 | M | Indirect | Held by the Shak Family Trust |
Common Stock | Acquisiton | 2019-02-28 | 5,000 | $28.05 | 360,479 | No | 4 | M | Indirect | Held by the Shak Family Trust |
Common Stock | Disposition | 2019-02-28 | 5,302 | $75.62 | 355,177 | No | 4 | S | Indirect | Held by the Shak Family Trust |
Common Stock | Disposition | 2019-02-28 | 14,900 | $76.41 | 340,277 | No | 4 | S | Indirect | Held by the Shak Family Trust |
Common Stock | Disposition | 2019-02-28 | 4,798 | $77.22 | 335,479 | No | 4 | S | Indirect | Held by the Shak Family Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Indirect | Held by the Shak Family Trust |
No | 4 | S | Indirect | Held by the Shak Family Trust |
No | 4 | S | Indirect | Held by the Shak Family Trust |
No | 4 | M | Indirect | Held by the Shak Family Trust |
No | 4 | M | Indirect | Held by the Shak Family Trust |
No | 4 | S | Indirect | Held by the Shak Family Trust |
No | 4 | S | Indirect | Held by the Shak Family Trust |
No | 4 | S | Indirect | Held by the Shak Family Trust |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2019-02-27 | 25,000 | $0.00 | 25,000 | $17.18 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2019-02-28 | 20,000 | $0.00 | 20,000 | $17.18 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2019-02-28 | 5,000 | $0.00 | 5,000 | $28.05 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
20,000 | 2020-02-18 | No | 4 | M | Direct | |
0 | 2020-02-18 | No | 4 | M | Direct | |
32,500 | 2023-01-31 | No | 4 | S | Direct |
Footnotes
- Includes an aggregate of 9,210 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on November 30, 2018.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Represents weighted average sale price. Actual sale prices ranged from $75.96 to $76.94.
- Represents weighted average sale price. Actual sale prices ranged from $76.96 to $77.76.
- Represents weighted average sale price. Actual sale prices ranged from $75.03 to $76.02.
- Represents weighted average sale price. Actual sale prices ranged from $76.06 to $77.05.
- Represents weighted average sale price. Actual sale prices ranged from $77.06 to $77.35.
- The option became exercisable as to 25% of the shares on February 18, 2011, and became exercisable as to 1/48th of the shares each full month thereafter.
- The option became exercisable as to 25% of the shares on January 31, 2014, and became exercisable as to 1/48th of the shares each full month thereafter.